• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sham surgery controls in Parkinson's disease clinical trials: views of participants.帕金森病临床试验中的假手术对照:参与者的观点。
Mov Disord. 2012 Sep 15;27(11):1461-5. doi: 10.1002/mds.25155. Epub 2012 Aug 23.
2
Procedure-Related Complications in Sham Surgeries for Parkinson's Clinical Trials: A Meta-analysis.临床试验中用于治疗帕金森的假手术相关并发症:荟萃分析。
Mov Disord. 2023 Jul;38(7):1223-1235. doi: 10.1002/mds.29406. Epub 2023 May 11.
3
Ethics of sham surgery: perspective of patients.假手术的伦理学:患者视角
Mov Disord. 2008 Jan;23(1):63-8. doi: 10.1002/mds.21775.
4
Sham surgery trial controls: perspectives of patients and their relatives.假手术试验对照组:患者及其亲属的观点。
J Empir Res Hum Res Ethics. 2012 Jul;7(3):15-28. doi: 10.1525/jer.2012.7.3.15.
5
The ethics of sham surgery in Parkinson's disease: back to the future?假手术治疗帕金森病的伦理问题:回到未来?
Bioethics. 2013 May;27(4):175-85. doi: 10.1111/j.1467-8519.2011.01931.x. Epub 2011 Dec 13.
6
Comparable indicators of therapeutic misconception between epilepsy or Parkinson's disease patients between those with clinical trial experience and trial non-participants.比较有临床试验经验和无临床试验经验的癫痫或帕金森病患者在治疗误解方面的可比指标。
Seizure. 2018 Aug;60:61-67. doi: 10.1016/j.seizure.2018.06.006. Epub 2018 Jun 9.
7
Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers.假手术的科学与伦理:帕金森病临床研究人员的调查
Arch Neurol. 2005 Sep;62(9):1357-60. doi: 10.1001/archneur.62.9.1357.
8
Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?治疗动机以及让自己的医生作为研究者是否是治疗误解的来源?
J Med Ethics. 2015 May;41(5):391-7. doi: 10.1136/medethics-2013-101987. Epub 2014 May 22.
9
Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson's disease and proposed criteria for use of sham surgery controls.假手术对照组:用于帕金森病的胎儿组织脑内移植及假手术对照组使用的建议标准。
J Med Ethics. 2002 Oct;28(5):322-5. doi: 10.1136/jme.28.5.322.
10
What motivates Parkinson's disease patients to enter clinical trials?是什么促使帕金森病患者参加临床试验?
Parkinsonism Relat Disord. 2011 Nov;17(9):667-71. doi: 10.1016/j.parkreldis.2011.05.023. Epub 2011 Jun 28.

引用本文的文献

1
Extracellular proteins as potential biomarkers in Sepsis-related cerebral injury.细胞外蛋白作为与脓毒症相关脑损伤相关的潜在生物标志物。
Front Immunol. 2023 Oct 13;14:1128476. doi: 10.3389/fimmu.2023.1128476. eCollection 2023.
2
Photobiomodulation in the management of oral mucositis for adult head and neck cancer patients receiving irradiation: the LiTEFORM RCT.光生物调节治疗成人头颈部癌症放疗患者口腔黏膜炎的效果:LiTEFORM RCT 研究
Health Technol Assess. 2022 Dec;26(46):1-172. doi: 10.3310/UWNB3375.
3
Patient and clinician characteristics and preferences for increasing participation in placebo surgery trials: a scoping review of attributes to inform a discrete choice experiment.患者和临床医生特征以及增加参与安慰剂手术试验的偏好:一项范围综述,用于为离散选择实验提供信息的属性。
Trials. 2022 Apr 12;23(1):296. doi: 10.1186/s13063-022-06277-x.
4
Patient and Caregiver Experiences of Participating in Parkinson's Disease Clinical Trials: A Systematic Review of Qualitative Studies.患者和照护者参与帕金森病临床试验的体验:定性研究的系统评价。
Arch Clin Neuropsychol. 2022 Feb 22;37(3):654-676. doi: 10.1093/arclin/acab083.
5
Placebo comparator group selection and use in surgical trials: the ASPIRE project including expert workshop.安慰剂对照比较组选择和在外科试验中的应用:包括专家研讨会的 ASPIRE 项目。
Health Technol Assess. 2021 Sep;25(53):1-52. doi: 10.3310/hta25530.
6
Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials.帕金森病患者的临床特征与治疗误解及参与临床试验的意愿相关。
Trials. 2017 Sep 29;18(1):444. doi: 10.1186/s13063-017-2174-2.
7
Randomised placebo-controlled trials of surgery: ethical analysis and guidelines.手术的随机安慰剂对照试验:伦理分析与指南
J Med Ethics. 2016 Dec;42(12):776-783. doi: 10.1136/medethics-2015-103333. Epub 2016 Oct 24.
8
What can we learn from trial decliners about improving recruitment? Qualitative study.关于改善招募工作,我们能从拒绝参与试验者身上学到什么?定性研究。
Trials. 2016 Oct 12;17(1):494. doi: 10.1186/s13063-016-1626-4.
9
Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?治疗动机以及让自己的医生作为研究者是否是治疗误解的来源?
J Med Ethics. 2015 May;41(5):391-7. doi: 10.1136/medethics-2013-101987. Epub 2014 May 22.
10
Attitudes and beliefs about placebo surgery among orthopedic shoulder surgeons in the United Kingdom.英国骨科肩关节外科医生对安慰剂手术的态度和看法。
PLoS One. 2014 Mar 14;9(3):e91699. doi: 10.1371/journal.pone.0091699. eCollection 2014.

本文引用的文献

1
Comparison of enrollees and decliners of Parkinson disease sham surgery trials.帕金森病假手术试验入组者和退出者的比较。
Mov Disord. 2012 Apr;27(4):506-11. doi: 10.1002/mds.24940. Epub 2012 Feb 7.
2
Experimental therapies for Parkinson's disease: Why fake it?帕金森病的实验性疗法:为何要造假?
Nature. 2011 Aug 10;476(7359):142-4. doi: 10.1038/476142a.
3
Open-label surgical trials for Parkinson disease: time for reconsideration.帕金森病的开放标签外科试验:是时候重新考虑了。
Ann Neurol. 2011 Jul;70(1):5-8. doi: 10.1002/ana.22453.
4
Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial.立体定向纹状体移植微载体结合的人视网膜色素上皮细胞与假手术治疗晚期帕金森病患者的随机双盲对照研究。
Lancet Neurol. 2011 Jun;10(6):509-19. doi: 10.1016/S1474-4422(11)70097-7. Epub 2011 May 10.
5
AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial.AAV2-GAD 基因治疗晚期帕金森病:一项双盲、假手术对照、随机试验。
Lancet Neurol. 2011 Apr;10(4):309-19. doi: 10.1016/S1474-4422(11)70039-4.
6
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial.AAV2-神经生长因子基因治疗帕金森病:一项双盲、随机、对照试验。
Lancet Neurol. 2010 Dec;9(12):1164-1172. doi: 10.1016/S1474-4422(10)70254-4. Epub 2010 Oct 20.
7
An approach to evaluating the therapeutic misconception.一种评估治疗错误观念的方法。
IRB. 2009 Sep-Oct;31(5):7-14.
8
Science and ethics of sham surgery: a survey of Parkinson disease clinical researchers.假手术的科学与伦理:帕金森病临床研究人员的调查
Arch Neurol. 2005 Sep;62(9):1357-60. doi: 10.1001/archneur.62.9.1357.
9
What is the risk of sham surgery in Parkinson disease clinical trials? A review of published reports.帕金森病临床试验中假手术的风险是什么?对已发表报告的综述。
Neurology. 2005 Oct 11;65(7):1101-3. doi: 10.1212/01.wnl.0000171957.90640.b5. Epub 2005 Jul 20.
10
Ethics of phase 1 oncology studies: reexamining the arguments and data.肿瘤学1期研究的伦理学:重新审视相关论据和数据。
JAMA. 2003 Aug 27;290(8):1075-82. doi: 10.1001/jama.290.8.1075.

帕金森病临床试验中的假手术对照:参与者的观点。

Sham surgery controls in Parkinson's disease clinical trials: views of participants.

机构信息

Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Mov Disord. 2012 Sep 15;27(11):1461-5. doi: 10.1002/mds.25155. Epub 2012 Aug 23.

DOI:10.1002/mds.25155
PMID:22927064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3703438/
Abstract

BACKGROUND

Sham surgery controls are increasingly used in neurosurgical clinical trials in Parkinson's disease (PD) but remain controversial. We interviewed participants of such trials, specifically examining their understanding and attitudes regarding sham surgery.

METHODS

We conducted semistructured qualitative interviews with participants of 3 sham surgery-controlled trials for PD, focusing on their understanding of sham design, their reactions to it, its impact on decision making, and their understanding of posttrial availability of the experimental intervention and its impact on decisions to participate.

RESULTS

All subjects (n = 90) understood the 2-arm design; most (86%) described the procedural differences between the arms accurately. Ninety-two percent referred to scientific or regulatory reasons as rationales for the sham control, with 62% specifically referring to the placebo effect. Ninety-one percent said posttrial availability of the experimental intervention had a strong (48%) or some (43%) influence on their decision to participate, but only 68% understood the conditions for posttrial availability.

CONCLUSIONS

Most subjects in sham surgery-controlled PD trials comprehend the sham surgery design and its rationale. Although there is room for improvement, most subjects of sham surgery trials appear to be adequately informed.

摘要

背景

假手术对照在帕金森病(PD)的神经外科临床试验中越来越多地被采用,但仍存在争议。我们对这些试验的参与者进行了访谈,专门研究了他们对假手术的理解和态度。

方法

我们对 3 项假手术对照 PD 临床试验的参与者进行了半结构式定性访谈,重点关注他们对假手术设计的理解、对其的反应、对决策的影响以及对试验后获得实验干预措施的理解及其对参与决策的影响。

结果

所有受试者(n=90)均理解 2 臂设计;大多数(86%)准确描述了手臂之间的程序差异。92%的人将科学或监管原因作为假手术对照的理由,其中 62%特别提到了安慰剂效应。91%的人表示试验后获得实验干预措施对他们的参与决定有很大(48%)或有些(43%)影响,但只有 68%的人理解试验后获得干预措施的条件。

结论

假手术对照 PD 试验的大多数受试者都理解假手术设计及其原理。尽管还有改进的空间,但假手术试验的大多数受试者似乎都得到了充分的告知。